Menu

Perrigo Company plc PRGO

Full chart Compare
Set alert

Price alert · PRGO

All alert types
15.85 USD +0.14 (+0.89%)

At closeNov 6, 2026, 4:05 PM EST

15.85 0.00 0.00%

After hours · Nov 6, 4:05 PM ET

15.25 Day range 15.97
9.23 52-week range 16.81
YTD
+13.86%
1 year
+6.16%
Market cap
2.20B
Revenue (ttm)
4.09B
Profit margin
-43.27%
EPS (ttm)
-12.47
Shares out
138.80M
Forward P/E
6.79
Dividend
1.16 (7.38%)
Ex-dividend date
Nov 26, 2026
YTD return
+13.86%
1-year return
+6.16%
Volume
2.31M
Avg volume
2.61M
Open
15.50
Previous close
15.71
Day's range
15.25 – 15.97
52-week range
9.23 – 16.81
Beta
0.69
Analysts
Buy
Price target
18.00 (+13.6%)
Earnings date
Feb 25, 2027

5D +0.08 (+0.51%)

15.501616.50MonTueWedThuFri15.85

Key statistics

Enterprise value
5.21B
PEG ratio
1.14
Price / sales
0.54
Price / book
0.90
Dividend yield
7.38%
Payout ratio
1348.75%
Revenue growth
-5.20%
Free cash flow
723.45M
Total cash
436.60M
Total debt
3.46B
Return on equity
-50.25%
Short % of float
26.72%
50-day average
14.93
200-day average
12.46

Financials — quick view

All financials
PRGO Revenue — quarterly 988.60M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
PRGO Net income — quarterly -27.50M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
PRGO EPS — quarterly -0.20
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

PRGO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Dec 26, 20260.758———
Nov 4, 2026Sep 26, 20260.5110.60+0.09+17.42%
Aug 5, 2026Jun 27, 20260.3880.50+0.11+28.87%
May 6, 2026Mar 28, 20260.390.43+0.04+10.26%
Feb 26, 2026Dec 31, 20250.800.77-0.03-3.75%
Nov 5, 2025Sep 27, 20250.750.80+0.05+6.67%

Upgrades / downgrades

PRGO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Canaccord GenuitymainBuyBuy
Feb 27, 2026Canaccord GenuitymainBuyBuy
Dec 15, 2025JP MorganmainNeutralNeutral
Nov 6, 2025Canaccord GenuitymainBuyBuy
Nov 6, 2025JP MorgandownOverweightNeutral
Oct 27, 2025JefferiesmainHoldHold

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Ireland
Website
perrigo.com

News

Your note

Sign in to keep a note on PRGO — it syncs with the Stock Master app.

Insider holders

PRGO insider holders
InsiderRelationLatest transactionDateShares held
ALFORD BRADLEY ADirectorConversion of Exercise of derivative securitySep 10, 202646,121
ASHFORD ORLANDO DDirectorConversion of Exercise of derivative securityMay 13, 202627,717
BEZERRA EDUARDO GUARITAChief Financial OfficerConversion of Exercise of derivative securityJun 4, 202684,700
JANISH RONALD CRAIGChief Technology OfficerConversion of Exercise of derivative securityApr 3, 202535,558
KARABOUTIS ADRIANADirectorConversion of Exercise of derivative securityMay 13, 202527,629
LOCKWOOD-TAYLOR PATRICKFormerConversion of Exercise of derivative securityJun 4, 2026123,170

Institution ownership

PRGO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.36%22,703,127359.96MJun 29, 2026
Neuberger Berman Group, LLC7.69%10,680,100169.33MJun 29, 2026
Vanguard Portfolio Management LLC6.52%9,045,661143.42MJun 29, 2026
Price (T.Rowe) Associates Inc6.27%8,700,421137.95MJun 29, 2026
State Street Corporation6.14%8,528,704135.22MJun 29, 2026
Fuller & Thaler Asset Management Inc.5.40%7,498,227118.88MJun 29, 2026

Fund ownership

PRGO fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%8,259,312130.95MSep 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.4.26%5,906,43693.65MJun 29, 2026
T. Rowe Price Mid-Cap Value Fund, Inc.3.27%4,541,19072.00MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%4,399,26169.75MJun 29, 2026
Invesco Exch-Trd Fd. TRT-Invesco High Yield Eqy. Dividend Achievers ET2.75%3,823,39760.62MAug 30, 2026
iShares Trust-iShares Russell 2000 ETF2.63%3,644,90957.79MSep 29, 2026